in vitro毒性試験：技術と世界市場

世界のin vitro（試験管内）毒性試験市場は、2025年に174億ドルと評価され、2025年から2030年にかけて年平均成長率（CAGR）10%で推移し、2030年末までに280億ドルに達するとBCC Researchでは予測しています。

本レポートの主な内容

• 175のデータ表および50の追加表
• インビトロ（in vitro）毒性試験の世界市場の概要
• 世界市場の動向に関する詳細な分析（2022～2024年の実績データ、2025年の推定値、2030年までの予測を含む）。2030年までの年平均成長率（CAGR）の予測も含まれます
• インビトロ毒性試験市場の現在の規模と収益成長見通しの評価。毒性エンドポイント、アッセイ（試験）タイプ、技術プラットフォーム、構成要素、エンドユーザー、地域別の市場シェア分析を併せて掲載
• インビトロ毒性試験の世界市場における現在および将来の需要分析、ならびに競争環境、市場規制、償還制度に関する詳細な分析
• 市場の成長に影響を与える促進要因、課題、機会の分析
• 進化する技術、現在および将来の市場ポテンシャル、研究開発（R&D）活動、成長戦略、新製品パイプライン、規制の枠組みと償還シナリオ、および市場におけるESG（環境・社会・ガバナンス）動向の網羅的な解説
• 主要市場参入企業のシェア分析、および各社の研究優先事項、製品ポートフォリオ、世界ランキング、競争状況の分析
• 業界の主要企業の企業概要（Thermo Fisher Scientific Inc.、Merck KGaA、Bio-Rad Laboratories Inc.、Agilent Technologies Inc.、Eurofins Scientific、Charles River Laboratories、SGS General Surveillance Co. SAなど）

本レポートは、世界のin vitro（試験管内）毒性試験市場について、現在の市場動向、新たなトレンド、将来の成長見通しを含む包括的な分析を提供します。この分析は、2024年を基準年とし、2025年の推定値および2025年から2030年にかけての年平均成長率（CAGR）の予測に基づいています。本レポートでは、世界市場および地域市場の双方を評価し、規制の進展、技術革新、業界慣行の変化が、in vitro毒性試験ソリューションの需要にどのような影響を与えているかについて考察します。

市場は、毒性エンドポイントおよび試験の種類（吸収・分布・代謝・排泄［ADME］試験、遺伝毒性試験、皮膚毒性、細胞毒性、眼毒性、皮膚刺激性・腐食性・感作性、臓器毒性、光毒性試験、発がん性、発生・生殖毒性［DART］、神経毒性、その他の毒性エンドポイントなど）によって区分されています。また、ツールおよび技術の観点からは、細胞培養技術、ハイスループットスクリーニング（HTS）、マルチオミクス、および高度なin vitroモデルや統合的な新規アプローチ手法（NAMs）といったその他の新興技術に区分されています。

Report Highlights

The global in vitro toxicity testing market was valued at $17.4 billion in 2025 and is projected to reach $28 billion by the end of 2030, at a compound annual growth rate of 10% from 2025 to 2030.

Report Includes

• 175 data tables and 50 additional tables
• An overview of the global market for in vitro toxicity testing
• In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
• Evaluation of the current market size and revenue growth prospects specific to in vitro toxicity testing, accompanied by a market share analysis by toxicity endpoints, assay types, technology platforms, components, end-users, and region
• Analysis of current and future demand in the global in vitro toxicity testing, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
• Analysis of drivers, challenges, and opportunities affecting market growth
• Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
• Market share analysis of the key market participants in in vitro toxicity testing, along with their research priorities, product portfolios, global rankings and company competitive landscape
• Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Merck KGaA, Bio‑Rad Laboratories Inc., Agilent Technologies Inc., Eurofins Scientific, Charles River Laboratories, and SGS General Surveillance Co. SA

Report Scope

This report offers a comprehensive analysis of the global in vitro toxicity testing market, including current market dynamics, emerging trends, and future growth prospects. The analysis is based on market data from 2024 as the base year, with estimates for 2025 and compound annual growth rate projections for the period from 2025 through 2030. The report evaluates both global and regional markets, providing insights into how regulatory evolution, technological innovation, and shifting industry practices are influencing demand for in vitro toxicity testing solutions.

The market is segmented by toxicity endpoint and test, including absorption, distribution, metabolism, and excretion (ADME) testing, genotoxicity testing, dermal toxicity, cytotoxicity, ocular toxicity, skin irritation, corrosion and sensitization, organ toxicity, phototoxicity testing, carcinogenicity, developmental and reproductive toxicity (DART), neurotoxicity, and other toxicity endpoints. By tool and technology, the market is segmented into cell culture technologies, high-throughput screening (HTS), multi-omics, and other emerging technologies, such as advanced in vitro models and integrated new approach methodologies.

By component, the report segments the market into equipment, reagents and kits, software and analytics, and services. By assay type, the market is segmented into cellular toxicity assays, biochemical toxicity assays, in silico assays, and other assay types, including advanced and hybrid approaches. By end-use segment, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations (CROs), cosmetics and personal care companies, and other end users, including chemicals, medical devices, agrochemicals, and academic or government research institutions. By region, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America.

Table of Contents

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Macroeconomic Factor Analysis
Impact of U.S. Tariffs on the Pharmaceutical Industry
Rising Pharmaceutical R&D Costs and Return on Investment Pressures
Impact of the Ukraine-Russia War on the In Vitro Toxicity Testing Industry
Porter’s Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Regulatory and Legislative Shift Toward Non-Animal Testing
Cost Efficiency and Early Attrition Reduction in Drug Development
Technological Maturation of Human-Relevant In Vitro Platforms and Data-Driven Toxicology
Market Restraints
Validation, Standardization, and Regulatory Acceptance Gaps
High Capital Intensity and Infrastructure Requirements
Limited Ability of In Vitro Systems to Capture Whole-System and Long-Term Toxicity
Market Opportunities
Regulatory Enablement and Validation Services
Personalized and Precision Toxicology Using Patient-Derived In Vitro Models
Chapter 4 Regulatory Landscape
Overview
U.S.
Europe
Asia-Pacific
Chapter 5 Emerging Technologies
Overview
Federal In Vitro Screening Programs and the Scale of Data Generation
Advanced Cell Systems: 3D Cultures and Human-Relevant Models
Microphysiological Systems and Organ-on-a-Chip Platforms
Mechanistic Biomarkers and Multi-Omics Evidence
Patent Analysis
Patents, by Year
Patents, by Jurisdiction
Patents, by Leading Inventor
Key Takeaways
Chapter 6 Market Segment Analysis
Segmentation Breakdown
Global Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test
Key Takeaways
ADME Testing
Genotoxicity Testing
Dermal Toxicity
Cytotoxicity
Ocular Toxicity
Skin Irritation, Corrosion, and Sensitization
Organ Toxicity
Phototoxicity Testing
Carcinogenicity
Neurotoxicity
DART
Others
Global In Vitro Toxicity Testing Market, by Tool/Technology
Key Takeaways
Cell Culture
High-Throughput Screening (HTS)
Multi-Omics
Others
Global In Vitro Toxicity Testing Market, by Component
Key Takeaways
Equipment
Reagents and Kits
Software and Analytics
Services
Global In Vitro Toxicity Testing Market, by Assays
Key Takeaways
Cellular Toxicity Assays
Biochemical Toxicity Assays
In Silico Assays
Others
Global In Vitro Toxicity Testing Market, by End-Use Industry
Key Takeaways
Pharmaceutical and Biotechnology
CROs
Cosmetics and Personal Care
Others
Geographic Breakdown
Global Market for In Vitro Toxicity Testing by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa
South America
Rest of South America
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Company Share Analysis
Chapter 8 Appendix
Methodology
Abbreviations
Sources
Company Profiles
ABCAM LTD.
AGILENT TECHNOLOGIES INC.
ARAGEN LIFE SCIENCES LTD.
BIO-RAD LABORATORIES INC.
BIOIVT
CHARLES RIVER LABORATORIES
EUROFINS SCIENTIFIC
EVOTEC SE
GENTRONIX
LABCORP.
MERCK KGAA
MOLECULAR DEVICES LLC.
PROMEGA CORP.
SGS Société Générale de Surveillance SA
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC
XENOMETRIX AG
Emerging Companies in the In Vitro Toxicity Testing Market

List of Tables

Summary Table : Global Market for In Vitro Toxicity Testing, by Region, Through 2030
Table 1 : Key Alternative Methods Accepted by U.S. Agencies
Table 2 : Patents Granted for In Vitro Toxicity Testing, by Inventor, January 2023–December 2025
Table 3 : Global Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 4 : Global Market for In Vitro Toxicity Testing for ADME Testing by Toxicity Endpoint and Test, by Region, Through 2030
Table 5 : Global Market for In Vitro Toxicity Testing for Genotoxicity by Toxicity Endpoint and Test, by Region, Through 2030
Table 6 : Global Market for In Vitro Toxicity Testing for Dermal Toxicity by Toxicity Endpoint and Test, by Region, Through 2030
Table 7 : Global Market for In Vitro Toxicity Testing for Cytotoxicity by Toxicity Endpoint and Test, by Region, Through 2030
Table 8 : Global Market for In Vitro Toxicity Testing for Ocular Toxicity by Toxicity Endpoint and Test, by Region, Through 2030
Table 9 : Global Market for In Vitro Toxicity Testing for Skin Irritation, Corrosion, and Sensitization by Toxicity Endpoint and Test, by Region, Through 2030
Table 10 : Global Market for In Vitro Toxicity Testing for Organ Toxicity by Toxicity Endpoint and Test, by Region, Through 2030
Table 11 : Global Market for In Vitro Toxicity Testing for Phototoxicity by Toxicity Endpoint and Test, by Region, Through 2030
Table 12 : Global Market for In Vitro Toxicity Testing for Carcinogenicity by Toxicity Endpoint and Test, by Region, Through 2030
Table 13 : Global Market for In Vitro Toxicity Testing for Neurotoxicity by Toxicity Endpoint and Test, by Region, Through 2030
Table 14 : Global Market for In Vitro Toxicity Testing for DART by Toxicity Endpoint and Test, by Region, Through 2030
Table 15 : Global Market for In Vitro Toxicity Testing for Other Toxicity Endpoints and Tests, by Region, Through 2030
Table 16 : Global Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 17 : Global Market for In Vitro Toxicity Testing for Cell Culture by Tool/Technology, by Region, Through 2030
Table 18 : Global Market for In Vitro Toxicity Testing for HTS by Tool/Technology, by Region, Through 2030
Table 19 : Global Market for In Vitro Toxicity Testing for Multi-Omics by Tool/Technology, by Region, Through 2030
Table 20 : Global Market for In Vitro Toxicity Testing for Other Tools and Technologies, by Region, Through 2030
Table 21 : Global Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 22 : Global Market for In Vitro Toxicity Testing for Equipment by Components, by Region, Through 2030
Table 23 : Global Market for In Vitro Toxicity Testing for Reagents and Kits by Components, by Region, Through 2030
Table 24 : Global Market for In Vitro Toxicity Testing for Software and Analytics by Components, by Region, Through 2030
Table 25 : Global Market for In Vitro Toxicity Testing for Services by Components, by Region, Through 2030
Table 26 : Global Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 27 : Global Market for In Vitro Toxicity Testing for Cellular Toxicity Assays, by Region, Through 2030
Table 28 : Global Market for In Vitro Toxicity Testing for Biochemical Toxicity Assays, by Region, Through 2030
Table 29 : Global In Vitro Toxicity Testing for In Silico Assays, by Region, Through 2030
Table 30 : Global In Vitro Toxicity Testing for Other Assays, by Region, Through 2030
Table 31 : Global Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 32 : Global Market for In Vitro Toxicity Testing for Pharmaceutical and Biotechnology by End-Use Industry, by Region, Through 2030
Table 33 : Global Market for In Vitro Toxicity Testing for CROs by End-Use Industry, Through 2030
Table 34 : Global Market for In Vitro Toxicity Testing for Cosmetics and Personal Care by End-Use Industry, by Region, Through 2030
Table 35 : Global Market for In Vitro Toxicity Testing for Other End-Use Industries, by Region, Through 2030
Table 36 : Global Market for In Vitro Toxicity Testing, by Region, Through 2030
Table 37 : North American Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 38 : North American Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 39 : North American Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 40 : North American Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 41 : North American Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 42 : North American Market for In Vitro Toxicity Testing, by Country, Through 2030
Table 43 : U.S. Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 44 : U.S. Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 45 : U.S. Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 46 : U.S. Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 47 : U.S. Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 48 : Canadian Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 49 : Canadian Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 50 : Canadian Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 51 : Canadian Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 52 : Canadian Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 53 : Mexican Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 54 : Mexican Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 55 : Mexican Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 56 : Mexican Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 57 : Mexican Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 58 : European Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 59 : European Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 60 : European Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 61 : European Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 62 : European Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 63 : European Market for In Vitro Toxicity Testing, by Country, Through 2030
Table 64 : German Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 65 : German Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 66 : German Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 67 : German Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 68 : German Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 69 : U.K. Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 70 : U.K. Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 71 : U.K. Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 72 : U.K. Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 73 : U.K. Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 74 : French Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 75 : French Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 76 : French Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 77 : French Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 78 : French Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 79 : Italian Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 80 : Italian Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 81 : Italian Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 82 : Italian Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 83 : Italian Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 84 : Spanish Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 85 : Spanish Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 86 : Spanish Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 87 : Spanish Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 88 : Spanish Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 89 : Rest of European Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 90 : Rest of European Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 91 : Rest of European Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 92 : Rest of European Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 93 : Rest of European Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 94 : Asia-Pacific Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 95 : Asia-Pacific Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 96 : Asia-Pacific Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 97 : Asia-Pacific Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 98 : Asia-Pacific Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 99 : Asia-Pacific Market for In Vitro Toxicity Testing, by Country, Through 2030
Table 100 : Chinese Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 101 : Chinese Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 102 : Chinese Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 103 : Chinese Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 104 : Chinese Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 105 : Japanese Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 106 : Japanese Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 107 : Japanese Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 108 : Japanese Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 109 : Japanese Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 110 : Indian Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 111 : Indian Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 112 : Indian Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 113 : Indian Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 114 : Indian Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 115 : South Korean Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 116 : South Korean Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 117 : South Korean Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 118 : South Korean Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 119 : South Korean Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 120 : Australian Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 121 : Australian Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 122 : Australian Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 123 : Australian Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 124 : Australian Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 125 : Rest of Asia-Pacific Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 126 : Rest of Asia-Pacific Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 127 : Rest of Asia-Pacific Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 128 : Rest of Asia-Pacific Market for In Vitro Toxicity Testing, by Assays,Through 2030
Table 129 : Rest of Asia-Pacific Market for In Vitro Toxicity Testing, by End-Use Industry,Through 2030
Table 130 : MEA Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, 2024
Table 131 : MEA Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 132 : MEA Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 133 : MEA Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 134 : MEA Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 135 : MEA Market for In Vitro Toxicity Testing, by Sub-Region, Through 2030
Table 136 : Middle East Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 137 : Middle East Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 138 : Middle East Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 139 : Middle East Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 140 : Middle East Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 141 : African Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 142 : African Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 143 : African Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 144 : African Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 145 : African Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 146 : South American Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 147 : South American Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 148 : South American Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 149 : South American Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 150 : South American Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 151 : South American Market for In Vitro Toxicity Testing, by Country, Through 2030
Table 152 : Brazilian Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 153 : Brazilian Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 154 : Brazilian Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 155 : Brazilian Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 156 : Brazilian Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 157 : Argentine Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 158 : Argentine Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 159 : Argentine Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 160 : Argentine Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 161 : Argentine Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 162 : Rest of South American Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2030
Table 163 : Rest of South American Market for In Vitro Toxicity Testing, by Tool/Technology, Through 2030
Table 164 : Rest of South American Market for In Vitro Toxicity Testing, by Component, Through 2030
Table 165 : Rest of South American Market for In Vitro Toxicity Testing, by Assays, Through 2030
Table 166 : Rest of South American Market for In Vitro Toxicity Testing, by End-Use Industry, Through 2030
Table 167 : News/Key Developments in the In Vitro Toxicity Testing Market, 2024 and 2025
Table 168 : Abbreviations Used in this Report
Table 169 : Report Sources
Table 170 : Abcam Ltd.: Company Snapshot
Table 171 : Abcam Ltd.: Product Portfolio
Table 172 : Agilent Technologies Inc.: Company Snapshot
Table 173 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
Table 174 : Agilent Technologies Inc.: Product Portfolio
Table 175 : Aragen Life Sciences Ltd.: Company Snapshot
Table 176 : Aragen Life Sciences Ltd.: Product Portfolio
Table 177 : Aragen Life Sciences Ltd.: News/Key Developments, 2023
Table 178 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 179 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
Table 180 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 181 : BioIVT: Company Snapshot
Table 182 : BioIVT: Product Portfolio
Table 183 : BioIVT: News/Key Developments, 2024
Table 184 : Charles River Laboratories: Company Snapshot
Table 185 : Charles River Laboratories: Financial Performance, FY 2023 and 2024
Table 186 : Charles River Laboratories: Product Portfolio
Table 187 : Charles River Laboratories: News/Key Developments, 2024 and 2025
Table 188 : Eurofins Scientific: Company Snapshot
Table 189 : Eurofins Scientific: Financial Performance, FY 2023 and 2024
Table 190 : Eurofins Scientific: Product Portfolio
Table 191 : EVOTEC SE: Company Snapshot
Table 192 : Evotec SE: Financial Performance, FY 2023 and 2024
Table 193 : Evotec SE: Product Portfolio
Table 194 : Evotec SE: News/Key Developments, 2023–2024
Table 195 : Gentronix: Company Snapshot
Table 196 : Gentronix: Product Portfolio
Table 197 : Gentronix: News/Key Developments, 2024
Table 198 : LabCorp.: Company Snapshot
Table 199 : LabCorp.: Financial Performance, FY 2023 and 2024
Table 200 : LabCorp.: Product Portfolio
Table 201 : LabCorp.: News/Key Developments, 2024
Table 202 : Merck KGaA: Company Snapshot
Table 203 : Merck KGaA: Financial Performance, FY 2023 and 2024
Table 204 : Merck KGaA: Product Portfolio
Table 205 : Merck KGaA: News/Key Developments, 2022–2025
Table 206 : Molecular Devices LLC.: Company Snapshot
Table 207 : Molecular Devices LLC: Product Portfolio
Table 208 : Molecular Devices LLC: News/Key Developments, 2024
Table 209 : Promega Corp.: Company Snapshot
Table 210 : Promega Corp.: Product Portfolio
Table 211 : SGS Société Générale de Surveillance SA: Company Snapshot
Table 212 : SGS Société Générale de Surveillance SA: Financial Performance, FY 2023 and 2024
Table 213 : SGS Société Générale de Surveillance SA: Product Portfolio
Table 214 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 215 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 216 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 217 : Thermo Fisher Scientific Inc.: News/Key Developments, 2024
Table 218 : WuXi AppTec: Company Snapshot
Table 219 : WuXi AppTec: Financial Performance, FY 2023 and 2024
Table 220 : WuXi AppTec: Product Portfolio
Table 221 : WuXi AppTec: News/Key Developments, 2022
Table 222 : Xenometrix AG: Company Snapshot
Table 223 : Xenometrix AG: Product Portfolio
Table 224 : Some Emerging Companies in the Global In Vitro Toxicity Testing Market

List of Figures

Summary Figure : Summary Figure: Global Market Shares of In Vitro Toxicity Testing, by Region, 2024
Figure 1 : Porter’s Five Forces Analysis of the In Vitro Toxicity Testing Market
Figure 2 : Market Dynamics of In Vitro Toxicity Testing
Figure 3 : Patents Granted In Vitro Toxicity Testing, by Year, January 2023–December 2025
Figure 4 : Patents Granted for In Vitro Toxicity Testing, by Leading Jurisdiction, January 2023–December 2025
Figure 5 : Global Market Shares of In Vitro Toxicity Testing, by Company, 2024
Figure 6 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2024
Figure 7 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2024
Figure 8 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2024
Figure 9 : Bio-Rad Laboratories Inc.: Revenue Share, by Region, FY 2024
Figure 10 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2024
Figure 11 : Charles River Laboratories: Revenue Share, by Area, FY 2024
Figure 12 : Eurofins Scientific: Revenue Share, by Business Unit, FY 2024
Figure 13 : Eurofins Scientific: Revenue Share, by Operating Segment, FY 2024
Figure 14 : Evotec SE: Revenue Share, by Business Unit, FY 2024
Figure 15 : Evotec SE: Revenue Share, by Region, FY 2024
Figure 16 : LabCorp.: Revenue Share, by Business Unit, FY 2024
Figure 17 : LabCorp.: Revenue Share, by Geography, FY 2024
Figure 18 : Merck KGaA: Revenue Share, by Business Unit, FY 2024
Figure 19 : Merck KGaA: Revenue Share, by Region, FY 2024
Figure 20 : SGS Société Générale de Surveillance SA: Revenue Share, by Business Unit, FY 2024
Figure 21 : SGS Société Générale de Surveillance SA: Revenue Share, by Geographical Area, FY 2024
Figure 22 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
Figure 23 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, FY 2024
Figure 24 : WuXi AppTec: Revenue Share, by Business Unit, FY 2024
Figure 25 : WuXi AppTec: Revenue Share, by Country/Region, FY 2024